Abstract
Diffuse neonatal hemangiomatosis (DNH) is a rare disorder that first presents with multiple cutaneous and visceral hemangiomas during the neonatal period and has a high mortality rate. The authors report a long-term survivor of DNH who presented with multiple visceral heman giomas without cutaneous lesions. Vascular endothelial growth factor (VEGF) may play an important role in tumor progression.
Get full access to this article
View all access options for this article.
References
1.
Ramdohr M.
: Ein fall von angebornem mutiplem angiosarcom . Virchows Arch
43 :459 -460 , 1878 .
2.
Golitz LE
,
Rudikoff J.
,
O'Meara OP
: Diffuse neonatal hemangiomatosis . Pediatr Dermatol
3 :145 -152 , 1986 .
3.
Stenninger E.
,
Schollin J.
: Diffuse neonatal hemangiomatosis in a newborn child . Acta Paediatr
82 :102 -104 , 1993 .
4.
Stratte EG
,
Tope WD
,
Johnson CL, et al
: Multimodal management of diffuse neonatal hemangiomatosis . J Am Acad Dermatol
34 (part 2 ):337 -342 , 1996 .
5.
Hamid RL
,
Marilyn JS
: Diffuse neonatal hemangiomatosis : CT findings in an adult . J Comput Assist Tomogr
16 :971 -973 , 1992 .
6.
Basilico C.
,
Moscatelli D.
: The FGF family of growth factors and oncogenesis . Adv Cancer Res
59 :115 -165 , 1992 .
7.
Ferrara NK
,
Davis-Smyth T.
: The biology of vascular endothelial growth factor . Endocr Rev
18 :4 -25 , 1997 .
8.
Spiller JC
,
Sharma V.
,
Woods GM, et al
: Diffuse neonatal hemangiomatosis treated successfully with interferon-alpha-2a . J Am Acad Dermatol
27 :102 -104 , 1992 .